Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATTACK aspirin in chronic kidney disease
ISRCTN40920200Phase 4Completed
- Sponsor
- University of Southampton
- Start
- Oct 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 4, randomised, open-label trial of aspirin in cardiac morbidity, myocardial infarction (MI) and stroke (2 arms), sponsored by University of Southampton. Primary endpoint: Time to first major vascular event. Started Oct 2018; status: completed.
02
Drugs
aspirin
03
Conditions
cardiac morbiditymyocardial infarction (MI)stroke
Beyond the preview
Go deeper on ISRCTN40920200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN40920200.